The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial. (2018)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0194197

PubMed Identifier: 29566026

Publication URI: http://europepmc.org/abstract/MED/29566026

Type: Journal Article/Review

Volume: 13

Parent Publication: PloS one

Issue: 3

ISSN: 1932-6203